The medical device company also added two new board members, one of which is Marilyn Carlson Nelson, the former CEO of hospitality company Carlson.
Health Care + Med Tech
The company’s flagship Diamondback 360 coronary device is expected to receive Shonin approval, which, if it does, will mark Cardiovascular Systems’ first step into an international market.
Study hints employers may need to increase incentives to use low-cost retail clinics for routine care.
They say benefits from sequencing genomes can’t be widely applied without changes.
The health system brought in about 1,200 replacement nurses during the two strikes this summer and fall.
The gene-editing company also signed Capitol Peak Asset Management to be its advisor on all future capitalization and strategic transactions.
The hospital system has adopted a number of different names since its founding in 1887 as Minneapolis City Hospital.
Patients face safety risks from health technologies designed to improve care.
Patent filed for ‘smart’ polymer that could have big implications for pharma pipelines.
Based on Mayo ‘cell senescence’ research, San Francisco-based Unity Biotechnology rakes in $116 million financing.
The sleep apnea specialist is looking to raise a total of $37.5 million in its latest investment round.
The telemedicine company hopes Brown can help expand its platform into new, untapped markets.
Deal includes investment in Silicon Valley digital health start-up AliveCor.
Generic drug sales double for Baudette-based company.
The issue of “overinfusion” with the medtech company’s SynchroMed II pump also led to more than 100 adverse events in other patients.
Brand-name drugs have been found to cost as much as 90 percent more than generic medicines.
Less than half of participating hospitals in state receive A's for patient safety.
Company switching gears to focus on new acquisition.